Marimed (MRMD) EV to CFO (2013 - 2026)

Marimed (MRMD) has reported EV to CFO for 14 consecutive years, with 7.99 the latest figure, recorded in Q2 2026.

• On a quarterly basis, EV to CFO fell 87.82% year-over-year to 7.99 in Q2 2026; TTM through Jun 2026 was 1.91, a 80.58% decrease from a year earlier, with the FY2025 full-year figure at 3.25, down 40.06% from the prior year.
• EV to CFO was 7.99 for Q2 2026 at Marimed, down from 19.07 in the prior quarter.
• Over five years, EV to CFO peaked at 106.69 in Q2 2023 and troughed at 88.97 in Q4 2024.
• A 5-year average of 21.79 and a median of 19.59 in 2025 frame the typical range for EV to CFO.
• Across the five-year window, EV to CFO jumped 547.44% in 2023 and slumped 424.55% in 2024, its largest moves.
• Over 5 years, EV to CFO stood at 64.23 in 2022, then plunged by 57.32% to 27.41 in 2023, then tumbled by 424.55% to 88.97 in 2024, then jumped by 108.19% to 7.28 in 2025, then increased by 9.75% to 7.99 in 2026.
• The last three EV to CFO figures came in at 7.99 (Q2 2026), 19.07 (Q1 2026), and 7.28 (Q4 2025), per Business Quant data.